Mupirocin
Regulatory milestones approvals, filings & regulatory actions · 2 recorded
| Milestone | Jurisdiction | Brand | Indication | Date | Sentence it was read from |
|---|---|---|---|---|---|
| Label expansion | US (FDA) | BACTROBAN | — | 1999-04-22 | fda.gov ↗ |
| Approved | US (FDA) | BACTROBAN | — | 1987-12-31 | fda.gov ↗ |
Trials 43
News releases announcing trial results or a regulatory action · 3
| Date | Issuer | Release |
|---|---|---|
| 2021-11-01 | Alembic Pharmaceuticals Ltd. | Regulatory Press Release Aleor USFDA Final Approval Mupirocin Cream USP, 2%. alembicpharmaceuticals.com ↗
Alembic Pharmaceuticals Limited (Alembic) today announced that its joint venture Aleor Dermaceuticals Limited (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Mupirocin Cream USP, 2%. |
| 2019-11-12 | Reig Jofre Group | Regulatory Reig Jofre and Ojer Pharma obtain the first European authorization for the commercialization of their innovative antibiotic Impetine Gel reigjofre.com ↗
First commercialization authorization obtained for the Portuguese market and authorization processes initiated in the rest of the European Union, in addition to Mexico and Canada. |
| 2003-11-09 | Teva Branded Pharmaceutical Products R&D, Inc. | Regulatory Teva Announces Approval Of Mupirocin Ointment tevapharm.com ↗
Teva Pharmaceutical Industries Ltd. (Nasdaq: TEVA) announced today that the U. S. Food and Drug Administration has approved the company's ANDA for Mupirocin Ointment USP, 2%. |
All press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2021-11-01 | Alembic Pharmaceuticals Ltd. | Press Release Aleor USFDA Final Approval Mupirocin Cream USP, 2%. alembicpharmaceuticals.com ↗ |
| 2019-11-12 | Reig Jofre Group | Reig Jofre and Ojer Pharma obtain the first European authorization for the commercialization of their innovative antibiotic Impetine Gel reigjofre.com ↗ |
| 2003-11-09 | Teva Branded Pharmaceutical Products R&D, Inc. | Teva Announces Approval Of Mupirocin Ointment tevapharm.com ↗ |
Evidence & citations 24 cited values
Every value below carries the sentence it was read from. 80 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Mupirocin | “Chlorhexidine gluconate 4% body scrub and 2% shampoo daily PLUS mupirocin 2%, fusidic acid 2%, or chlorhexidine gluconate 0.2% intranasally bid PLUS...” NCT01232231 ↗77“Validated decolonization regimen consisting of intranasal 2% mupirocin ointment applied twice daily as well as chlorhexidine wash used daily to the body.” NCT05505214 ↗ “Topical intranasal mupirocin ointment (bilateral nares, twice daily) x5 days if non-critical care patients are MRSA+ by history, culture, or screen.” NCT02063867 ↗ “The antibiotic would be selected from Levaquin, Vancomycin, Gentamicin, Ciprofloxacin, Mupirocin, and Trimethoprim/Sulfamethoxazole” NCT03303677 ↗ “Households will undergo decolonization for MRSA with Mupirocin nasal ointment and Hibiclens body wash.” NCT00966446 ↗ “Provider choice of topical antibiotics includes Mupirocin 0.4mg/ml” NCT03935828 ↗ “nasal mupirocin for 5 days twice per month for 6 months” PMID 30763195 ↗ Feb 2019 “application of mupirocin ointment over the skin staples” NCT03081962 ↗ “mupirocin ointment into both nares BID for 2 weeks.” NCT01229553 ↗ “Mupirocin 2% nasal ointment to the anterior nares” NCT06397781 ↗ “use of mupirocin nasal ointment 3 times a day” NCT02945722 ↗ |
| Known as | Bactoderm | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Bactroban | “Those colonized were randomized in a double-blind fashion to nasal mupirocin (Bactroban) twice daily and hexachlorophene (pHisoHex) soaps daily for 7 days compared to placeboes...” PMID 26018036 ↗ May 20151“Bactroban® (mupirocin) 2% cream” NCT00626795 ↗ |
| Known as | BACTROBAN NASAL | “For this clinical trial, all subjects will be given: nasal mupirocin (Bactroban Nasal, twice daily), topical 3% hexachlorophene body wash (Phisohex, daily), and an oral...” NCT01049438 ↗2“Mupirocin (Bactroban Nasal): twice a day for 7 days, apply one pea-sized amount of Bactroban Nasal ointment directly into one nostril and another pea-sized amount for the other nostril.” NCT00560599 ↗ “BACTROBAN NASAL ointment (mupirocin calcium ointment, 2%) for use intranasally twice-daily on Day 1, 2, 3, 4 and 5 of Week 8 of the study.” NCT04218799 ↗ |
| Known as | BACTROBAN Nasal ong | “Mupirocin, BACTROBAN® Nasal ong, 3g, GSK” NCT03962907 ↗ |
| Known as | BRL 4910A | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | BRL 4910F | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Calcium mupirocin | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Calcium mupirocin dihydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Calcium pseudomonate | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Centany | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | mupirocin calcium | “BACTROBAN NASAL ointment (mupirocin calcium ointment, 2%) for use intranasally twice-daily on Day 1, 2, 3, 4 and 5 of Week 8 of the study.” NCT04218799 ↗ |
| Known as | Mupirocin calcium anhydrous | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Mupirocin calcium dihydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Mupirocin calcium hydrate | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Mupirocina | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Mupirocine | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | NSC-759182 | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Pseudomonic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Trans-pseudomonic acid | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Known as | Turixin | ChEMBL registry synonym — accepted as the source's own label CHEMBL719 ↗ |
| Action | Inhibit | “This medicine works by killing bacteria or preventing their growth.” NCT06712433 ↗ |
| Modality | Small molecule | — CHEMBL719 ↗ |
| Route | Topical | “Drug or placebo will be applied topically to nares and/or wounds twice daily” NCT00108160 ↗ |